This is what biosimilars stand for!
same quality
more supply
less costs
We must not repeat the same mistake!
Peter Stenico, chairman of AG Pro Biosimilars, warns against automatic substitution in biosimilars: "We've seen what cost pressures do to generics: production migration and a supply that becomes more unstable."
